Skip to main content
. 2018 Sep 17;10:3589–3597. doi: 10.2147/CMAR.S172261

Figure 4.

Figure 4

Kaplan–Meier curve analyses of PFS. There was no significant difference in PFS in terms of bevacizumab treatment in both the low PC group (A) and the high PC group (B).

Abbreviations: PFS, progression-free survival; PC, perivascular cell coverage.